merged_alzheimers-blood-test.txt
<question_number>1</question_number>
<answer>There is a risk of anxiety and other psychological reactions in people without cognitive impairment if Alzheimer's pathology is detected, since there are currently no therapies to offer.</answer>

<question_number>2</question_number>
<answer>Primary care doctors were wrong 41% of the time when they thought patients did not have Alzheimer's.</answer>

<question_number>3</question_number>
<answer>The blood test was less accurate in patients with subjective cognitive decline because many people with this early stage do not end up having Alzheimer's.</answer>

<question_number>4</question_number>
<answer>The blood test analysis needs to be easily integrated into hospital laboratory systems rather than requiring outside labs.</answer>

<question_number>5</question_number>
<answer>Measuring the form of the tau protein called ptau-217 provided the most accurate assessment of Alzheimer's pathology compared to other blood tests.</answer>

<question_number>6</question_number>
<answer>Blood tests should only be used for people with memory loss and other symptoms of cognitive decline, not for predicting Alzheimer's in cognitively healthy people.</answer>

<question_number>7</question_number>
<answer>Kidney disease can cause high ptau-217 levels not linked to Alzheimer's.</answer>

<question_number>8</question_number>
<answer>Experts are concerned that using blood tests to predict future Alzheimer's development in cognitively healthy people could lead to anxiety and other psychological reactions, since there are currently no preventative treatments available.</answer>

<question_number>9</question_number>
<answer>41%</answer>

<question_number>10</question_number>
<answer>Using blood tests in primary care could increase access to Alzheimer's screening, especially for racial/ethnic minorities and low-income/rural communities.</answer>